Deciphering complex mechanisms of resistance and loss of potency through coupled molecular dynamics and machine learning [preprint]
UMass Chan AffiliationsSchiffer Lab
Department of Biochemistry and Molecular Pharmacology
Artificial Intelligence and Robotics
Enzymes and Coenzymes
Medicinal Chemistry and Pharmaceutics
MetadataShow full item record
AbstractDrug resistance threatens many critical therapeutics through mutations in the drug target. The molecular mechanisms by which combinations of mutations, especially involving those distal from the active site, alter drug binding to confer resistance are poorly understood and thus difficult to counteract. A strategy coupling parallel molecular dynamics simulations and machine learning to identify conserved mechanisms underlying resistance was developed. A series of 28 HIV-1 protease variants with up to 24 varied substitutions were used as a rigorous model of this strategy. Many of the mutations were distal from the active site and the potency to darunavir varied from low pM to near μM. With features extracted from molecular dynamics simulations, elastic network machine learning was applied to correlate physical interactions at the molecular level with potency loss. This fit to within 1 kcal/mol of experimental potency for both the training and test sets, outperforming MM/GBSA calculations. Feature reduction resulted in a model with 4 specific features that correspond to interactions critical for potency regardless of enzyme variant. These predictive features throughout the enzyme would not have been identified without dynamics and machine learning and specifically varied with potency. This approach enables capturing the conserved dynamic molecular mechanisms by which complex combinations of mutations confer resistance and identifying critical interactions which serve as bellwethers over a wide range of inhibitor potency. Machine learning models leveraging molecular dynamics can thus elucidate mechanisms that confer loss of affinity due to variations distal from the active site, such as in drug resistance.
bioRxiv 2020.06.08.139105; doi: https://doi.org/10.1101/2020.06.08.139105. Link to preprint on bioRxiv service.
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/29482
Now published in J Chem Theory Comput., doi: 10.1021/acs.jctc.0c01244
RightsThe copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY-NC-ND 4.0 International license.
Except where otherwise noted, this item's license is described as The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY-NC-ND 4.0 International license.